室间隔缺损修补术临床路径的应用效益分析  

Application Evaluation of Clinical Pathway in the repair of ventricular septal defect

作　　者：吴鲁卿[1] 谢翠贤[1] 黄晶晶[1] 王继勇[1] 孙志佳[1] 郭亚雄[1] 杨明[1] 沈春辉[1] 吴志钰[1] 郑惠萍[1] 

机构地区：[1]广州中医药大学第一附属医院心胸血管外科,广东广州510405

出　　处：《吉林医学》2016年第3期708-710,共3页Jilin Medical Journal

摘　　要：目的:探讨临床路径(Clinical pathway,CP)在行室间隔缺损修补术的患者的医疗管理中的应用效益。方法:选择成功行体外循环下单纯室间隔缺损修补术的患者,根据是否实施了临床路径管理分为CP组和非CP组。对两组患者的医疗临床指标及医疗质量指标进行对比分析。结果:204例患者(男92/女112)成功接受室间隔缺损修补术,CP组106例,非CP组98例。CP组平均住院天数、平均术前评估天数、平均抗菌药使用天数、平均住院总费用、平均药品费用均低于非CP组,差异均有统计学意义(P<0.01)。两组并发症发生率差异无统计学意义(P=0.81),CP组甲级病历率及患者满意度明显提高(P<0.05)。结论:临床路径是提高室间隔缺损修补术医疗管理质量的有效方法。Objective To investigate the applicational effects of clinical pathway（ CP） in the medical therapy management of the patients who received repair of ventricular septal defect（ VSD）. Method All patients with VSD received repair operation by cardiopulmonary bypass successfully were divided into two groups,CP group and non- CP group,according to whether they have accepted CP management. To conduct a comparative analysis on medical clinical index and medical quality index of the two groups. Results 204 patients（ 92 men and 112 women） received repair of VSD successfully,including 106 patients in CP group,98 patients in non- CP group. The average length of stay、preoperative evaluation and antimicrobial drug use and the average expense of hospitalization and drug were all decreased in the CP group and the difference was statistically significant（ P〈0. 01）. There was no statistical difference in the overall complications rate between the two groups（ P = 0. 81）,and the rate of class A medical records and patients satisfaction was significantly increased in the CP group（ P〈0. 05）. Conclusion Clinical pathway is an effective method for improving the quality of medical therapy management of repair of VSD.

关 键 词：室间隔缺损 临床路径 医疗管理 

分 类 号：R473.72[医药卫生—护理学]